USPTO serial 78812293
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for use in the treatment, cure, mitigation and/or prevention of gingivitis, halitosis, stomatitis, periodontitis, inflammation of the oral cavity, inflammation of the pharyngeal cavity, sore mouth, sore gums, sore throat, injury of the mouth and gums, periodontal diseases, dental caries, hypersensitivity of teeth; pharmaceutical preparations for sore mouth, sore gums, sore throat, pain associated with canker sores, pain due to minor irritation or injury of the mouth and gums, pain due to minor dental procedures, pain due to minor irritations caused by dentures or orthodontic appliances, sore gums due to teething in infants and children four months of age and older, pain due to gingivitis, stomatitis, periodontitis, hypersensitivity of teeth and other diseases and conditions of the mouth, gums, oral cavity and pharyngeal cavity; veterinary preparations for use in the treatment, cure, mitigation and/or prevention of gingivitis, halitosis, stomatitis, periodontitis, inflammation of the oral cavity, inflammation of the pharyngeal cavity, sore mouth, sore gums, sore throat, injury of the mouth and gums, periodontal diseases, dental caries, hypersensitivity of teeth; plant extracts for veterinary and pharmaceutical purposes; pharmaceutical products, namely, medicated dental gums and mouth washes, medicated mouth rinse, plaque disclosing reagents; periodontal diagnostic reagents for detecting derivatives from periodontal bacteria, caries diagnostic reagents for detecting derivatives from caries-causal bacteria; pharmaceutical products, namely, medicines for the prevention and treatment of periodontal diseases, dental caries, canker sores, cold sores, mucositis and oral and tongue cancers; pharmaceutical products, namely, medicated toothpastes, medicated oral-care gels, medicated dental gels, lozenges in the nature of throat lozenges, medicated lozenges, cough lozenges, medicated chewing gum; pharmaceutical products, namely, medicated gels and fluids in the nature of dental bleaching gels, gums, balms; pharmaceutical products, namely, medicated chewing gums and lozenges which provide a protective dental gingival barrier, coating and sealant for preventive, prophylactic, therapeutic hygiene use; pharmaceutical products, namely medicated dental floss, medicated dental tapes, medicated dental ribbons, medicated teeth whitening gels, medicated toothpicks, fluoride chewing gum, chewable tablets for disclosing dental plaque and tartar; pharmaceutical products, namely, antiseptics, oral antiseptics, disinfectants for hygienic purposes; pharmaceutical products, namely, mouth sprays which provide a protective dental gingival barrier, coating and sealant for preventative, prophylactic, therapeutic hygiene use and dentin desensitizers; pharmaceutical products, namely, medicated dentifrices; dietary supplements; food supplements and dietary food supplements | ABANDONED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2009 | MAB5 | ABANDONMENT NOTICE MAILED - AFTER PUBLICATION | — |
| Oct 8, 2009 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Oct 7, 2009 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Sep 10, 2009 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Sep 10, 2009 | EXT3 | SOU EXTENSION 3 FILED | — |
| Sep 10, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 2, 2009 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Mar 2, 2009 | EXT2 | SOU EXTENSION 2 FILED | — |
| Mar 2, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 27, 2008 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 27, 2008 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 27, 2008 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 11, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 18, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 28, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 15, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 15, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 25, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Oct 25, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 25, 2007 | ALIE | ASSIGNED TO LIE | — |
| Sep 17, 2007 | PAPER RECEIVED | — | |
| Mar 21, 2007 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 21, 2007 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 28, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Feb 28, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 28, 2007 | ALIE | ASSIGNED TO LIE | — |
| Jan 31, 2007 | PAPER RECEIVED | — | |
| Aug 2, 2006 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 1, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 1, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 16, 2006 | NWAP | NEW APPLICATION ENTERED | — |